Literature DB >> 25347711

Isolation of epithelial, endothelial, and immune cells from lungs of transgenic mice with oncogene-induced lung adenocarcinomas.

Amlak Bantikassegn1, Xiaoling Song, Katerina Politi.   

Abstract

Genetically engineered mouse models of lung adenocarcinoma have proven invaluable for understanding mechanisms of tumorigenesis, therapy response, and drug resistance. However, mechanistic studies focused on studying these processes in tumor-bearing mouse lungs are confounded by the fact that, in most cases, relevant signaling pathways are analyzed in whole-lung preparations, which are composed of a heterogeneous mixture of cells. Given our increasing knowledge about the roles played by different subpopulations of cells in the development of lung adenocarcinoma, separating the major cellular compartments of the tumor microenvironment is recommended to allow for a precise analysis of relevant pathways in each isolated cell type. In this study, we optimized magnetic- and fluorescence-based isolation protocols to segregate lung epithelial (CD326/epithelial cell adhesion molecule-positive), endothelial (CD31-positive), and immune (CD45-positive) cells, with high purity, from the lungs of transgenic mice with mutant epidermal growth factor receptor-induced lung adenocarcinomas. This approach, which can potentially be extended to additional lung adenocarcinoma models, enables delineation of the molecular features of individual cell types that can be used to gain insight into their roles in lung adenocarcinoma initiation, progression, and response to therapy.

Entities:  

Keywords:  epithelial cell adhesion molecule; epithelial cell isolation; lung adenocarcinoma; transgenic mouse models

Mesh:

Substances:

Year:  2015        PMID: 25347711      PMCID: PMC4491125          DOI: 10.1165/rcmb.2014-0312MA

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  40 in total

1.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Authors:  G H Fisher; S L Wellen; D Klimstra; J M Lenczowski; J W Tichelaar; M J Lizak; J A Whitsett; A Koretsky; H E Varmus
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 3.  Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker.

Authors:  F Broeckaert; A Bernard
Journal:  Clin Exp Allergy       Date:  2000-04       Impact factor: 5.018

4.  Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.

Authors:  Huan-Chieh Cho; Chao-Yang Lai; Li-En Shao; John Yu
Journal:  Cancer Res       Date:  2011-11-16       Impact factor: 12.701

5.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.

Authors:  Li Yang; Laura M DeBusk; Koari Fukuda; Barbara Fingleton; Brenda Green-Jarvis; Yu Shyr; Lynn M Matrisian; David P Carbone; P Charles Lin
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

6.  Identification and isolation of mouse type II cells on the basis of intrinsic expression of enhanced green fluorescent protein.

Authors:  Jason M Roper; Rhonda J Staversky; Jacob N Finkelstein; Peter C Keng; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-09       Impact factor: 5.464

7.  Alveolar type I and type II cells.

Authors:  H E Ward; T E Nicholas
Journal:  Aust N Z J Med       Date:  1984-10

8.  Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Authors:  G Stenhouse; N Fyfe; G King; A Chapman; K M Kerr
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

Review 9.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15

10.  A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity.

Authors:  Claudio Di Paolo; Jörg Willuda; Susanne Kubetzko; Ikar Lauffer; Dominique Tschudi; Robert Waibel; Andreas Plückthun; Rolf A Stahel; Uwe Zangemeister-Wittke
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 13.801

View more
  24 in total

1.  O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.

Authors:  Kekoa Taparra; Hailun Wang; Reem Malek; Audrey Lafargue; Mustafa A Barbhuiya; Xing Wang; Brian W Simons; Matthew Ballew; Katriana Nugent; Jennifer Groves; Russell D Williams; Takumi Shiraishi; James Verdone; Gokben Yildirir; Roger Henry; Bin Zhang; John Wong; Ken Kang-Hsin Wang; Barry D Nelkin; Kenneth J Pienta; Dean Felsher; Natasha E Zachara; Phuoc T Tran
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

2.  The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors:  Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

Review 3.  Epigenetic control of the tumor microenvironment.

Authors:  David L Marks; Rachel Lo Olson; Martin E Fernandez-Zapico
Journal:  Epigenomics       Date:  2016-10-04       Impact factor: 4.778

4.  Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid-Derived Suppressor Cells.

Authors:  Michael P Plebanek; Debayan Bhaumik; Paul J Bryce; C Shad Thaxton
Journal:  Mol Cancer Ther       Date:  2017-12-27       Impact factor: 6.261

5.  Dissociation, cellular isolation, and initial molecular characterization of neonatal and pediatric human lung tissues.

Authors:  Gautam Bandyopadhyay; Heidie L Huyck; Ravi S Misra; Soumyaroop Bhattacharya; Qian Wang; Jared Mereness; Jacquelyn Lillis; Jason R Myers; John Ashton; Timothy Bushnell; Matthew Cochran; Jeanne Holden-Wiltse; Philip Katzman; Gail Deutsch; Jeffrey A Whitsett; Yan Xu; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-05       Impact factor: 5.464

6.  Absence of Endothelial ERα Results in Arterial Remodeling and Decreased Stiffness in Western Diet-Fed Male Mice.

Authors:  Camila Manrique-Acevedo; Francisco I Ramirez-Perez; Jaume Padilla; Victoria J Vieira-Potter; Annayya R Aroor; Brady J Barron; Dongqing Chen; Dominic Haertling; Cory Declue; James R Sowers; Luis A Martinez-Lemus
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

7.  Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.

Authors:  Melissa L Wilkinson; Elena Abramova; Changjiang Guo; James G Gow; Alexa Murray; Adolf Koudelka; Veronika Cechova; Bruce A Freeman; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

8.  Flow-cytometric method for simultaneous analysis of mouse lung epithelial, endothelial, and hematopoietic lineage cells.

Authors:  Benjamin D Singer; Jason R Mock; Franco R D'Alessio; Neil R Aggarwal; Pooja Mandke; Laura Johnston; Mahendra Damarla
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-04       Impact factor: 5.464

9.  Nanoparticles for delivery of agents to fetal lungs.

Authors:  Sarah J Ullrich; Mollie Freedman-Weiss; Samantha Ahle; Hanna K Mandl; Alexandra S Piotrowski-Daspit; Katherine Roberts; Nicholas Yung; Nathan Maassel; Tory Bauer-Pisani; Adele S Ricciardi; Marie E Egan; Peter M Glazer; W Mark Saltzman; David H Stitelman
Journal:  Acta Biomater       Date:  2021-01-21       Impact factor: 8.947

Review 10.  Comprehensive phenotyping of endothelial cells using flow cytometry 1: Murine.

Authors:  Dillon Grant; Nicholas Wanner; Matthew Frimel; Serpil Erzurum; Kewal Asosingh
Journal:  Cytometry A       Date:  2020-12-20       Impact factor: 4.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.